We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

By LabMedica International staff writers
Posted on 26 Jul 2024
Print article
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker for early diagnosis of this prevalent movement disorder. Research has demonstrated that the pathophysiologically significant protein alpha-synuclein, known to accumulate in the nerve cells of PD patients, can also be found in various body fluids and tissues, such as cerebrospinal fluid or skin. Now, researchers have discovered that a blood test for detecting alpha-synuclein could offer a feasible, less invasive method for diagnosing PD.

Previously, a research team at University Hospital Schleswig-Holstein (UKSH, Kiel, Germany) had demonstrated that alpha-synuclein could be detected in the blood of PD patients by isolating neuronal exosomes, or small vesicles from neuronal cells, in the blood and amplifying the contained alpha-synuclein using a seed amplification assay (SAA). Their latest study, published in the Journal of Parkinson's Disease, sought to validate the efficacy of this blood test in a broader cohort of PD individuals and to investigate how alpha-synuclein levels, as measured by SAA, may vary as the disease progresses.

In this study, researchers analyzed cross-sectional blood samples from PD patients and compared them with those from age- and gender-matched healthy controls using the blood-based SAA. Out of 80 PD patients tested, 79 showed positive results for alpha-synuclein seeding in the blood, whereas none of the healthy controls tested positive. This high sensitivity of the alpha-synuclein blood marker for PD was thus confirmed. Additionally, when analyzing subgroups of PD patients with varying disease durations, those with longer disease durations exhibited lower alpha-synuclein seeding activity. This indicates that alpha-synuclein seeding activity may change throughout the disease's progression. However, it is still uncertain how alpha-synuclein seeding activity naturally evolves over the course of PD.

"There is currently no blood test for PD available in clinical practice. It is of course of great importance that the strong results of our cross-sectional and longitudinal analyses are validated and replicated in different labs. If the decline in seeding activity in blood was confirmed, it may influence further studies and our understanding of disease progression,” said lead investigators Annika Kluge, MD, and Eva Schaeffer, MD, both of the Department of Neurology, University Hospital Schleswig-Holstein. “In the long term, it is hoped that this blood test can be used to improve the diagnostic security and reliability in PD, even at early stages during which clinical diagnosis is difficult. Moreover, the impact on clinical studies needs to be considered, especially regarding the potential of antibody-based targeted treatments for PD."

Related Links:
UKSH

New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.